Clinical trial
A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment…
NCT00216385 · Institut de Recherche pour le Developpement, Other · Unknown status
Key facts
| NCT number | NCT00216385 |
|---|---|
| Title | A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary Tuberculosis |
| Official title | A Randomised Open-Label Controlled Trial of a 4-Month Gatifloxacin-Containing Regimen Versus Standard Regimen for the Treatment of Adult Patients With Pulmonary Tuberculosis |
| Lead sponsor | Institut de Recherche pour le Developpement, Other |
| Collaborators | World Health Organization European Commission |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Tuberculosis |
| Intervention type | Drug |
| Interventions | Gatifloxacin combined regimen |
| Enrollment | 2,070 |
| Start date | Jan 1, 2005 |
| Completion | Dec 1, 2008 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 22, 2005 |
| Countries | Benin, Guinea, Kenya, Senegal, South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: